- Home
- FORR vs PRQR Comparison
FORR vs PRQR Comparison
Compare FORR & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FORR
- PRQR
- Stock Information
- Founded
- FORR 1983
- PRQR 2012
- Country
- FORR United States
- PRQR Netherlands
- Employees
- FORR N/A
- PRQR N/A
- Industry
- FORR Diversified Commercial Services
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- FORR Consumer Discretionary
- PRQR Health Care
- Exchange
- FORR Nasdaq
- PRQR Nasdaq
- Market Cap
- FORR 193.5M
- PRQR 179.1M
- IPO Year
- FORR 1996
- PRQR 2014
- Fundamental
- Price
- FORR $9.44
- PRQR $2.26
- Analyst Decision
- FORR
- PRQR Strong Buy
- Analyst Count
- FORR 0
- PRQR 8
- Target Price
- FORR N/A
- PRQR $8.88
- AVG Volume (30 Days)
- FORR 71.9K
- PRQR 342.1K
- Earning Date
- FORR 07-31-2025
- PRQR 08-07-2025
- Dividend Yield
- FORR N/A
- PRQR N/A
- EPS Growth
- FORR N/A
- PRQR N/A
- EPS
- FORR N/A
- PRQR N/A
- Revenue
- FORR $422,269,000.00
- PRQR $21,212,711.00
- Revenue This Year
- FORR N/A
- PRQR N/A
- Revenue Next Year
- FORR $2.04
- PRQR N/A
- P/E Ratio
- FORR N/A
- PRQR N/A
- Revenue Growth
- FORR N/A
- PRQR 85.91
- 52 Week Low
- FORR $8.50
- PRQR $1.07
- 52 Week High
- FORR $20.62
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- FORR 41.42
- PRQR 56.82
- Support Level
- FORR $9.47
- PRQR $2.27
- Resistance Level
- FORR $10.00
- PRQR $2.51
- Average True Range (ATR)
- FORR 0.41
- PRQR 0.13
- MACD
- FORR -0.07
- PRQR -0.00
- Stochastic Oscillator
- FORR 7.52
- PRQR 51.49
About FORR Forrester Research Inc.
Forrester Research Inc provides independent research, data, and advisory services. It operates through the following segments: The Research segment develops and delivers research, connect, and analytics products; The consulting segment includes the revenues and the related costs of the company's consulting organization, and the Events segment is engaged in developing and hosting in-person and virtual events.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.